Buy Crypto Markets Spot FuturesIOST Earn Event Center Rewards Hub

Guardant Health, Inc. (GH)

NASDAQ

$161.09

$-2.30

(-1.41%)

Pre-Market

Guardant Health, Inc. (GH) Live Price Chart

Last updated: ⁦2026-09-10 10:42:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Guardant Health, Inc. (GH) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $161.09, with a market capitalization of $21.60B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $53.40 to $176.58. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$21.60B
Open	$163.39
Day's High	$181.07
Day's Low	$15.81
Previous Close	$162.78
Volume	160.00
Average Volume	2.51M
P/E Ratio	--
52-Week High	$176.58
52-Week Low	$53.40
Dividend Yield	--
Earnings Date	--

Guardant Health, Inc. (GH) Pre-Market Stock Price

Guardant Health, Inc. (GH) is trading at $161.09 in pre-market trading as of 2026-09-10 10:22:00, down 1.04% ($1.69) from the previous close of $162.78

Pre-market trading shows how investors are pricing GH before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Guardant Health, Inc. (GH) 7-Day Stock Price Change

Over the past seven days, Guardant Health, Inc. (GH) moved from $159.02 to $161.09, representing a gain of 1.30% ($2.06).

The stock traded between $154.00 and $168.97 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 1.83 million shares, down versus the previous seven-day period, indicating lower trading activity.

GH 52-Week Price Position

Position in Range: 87.4%

52W Low$53.40

52W High$176.58

GH is currently trading at $161.09, placing it 87.4% of the way from its 52-week low of $53.40 to its 52-week high of $176.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Guardant Health, Inc. (GH)?

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health, Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	2506
Exchange	NASDAQ
Company Website	https://www.guardanthealth.com

How to Buy Guardant Health, Inc. (GH) Stock on MEXC

Eligible investors can buy real shares of Guardant Health, Inc. (GH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GH and Place Your Order

Open the RealStocks trading page and search for GH. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Guardant Health, Inc. (GH) stock price today?

Guardant Health, Inc. (GH) is currently trading at $ 161.09, down 1.04% ($1.69) from the previous close of $ 162.78. Intraday prices update in real time during regular trading hours.

2.Is GH stock going up or down today?

As of 2026-09-10 10:22:00, GH is trading at $ 161.09, down 1.04% ($1.69) from its previous close of $ 162.78. The stock has traded between $ 15.81 and $ 181.07 during today’s regular session. Past price movements do not guarantee future results.

3.What is GH pre-market price?

As of 2026-09-10 10:22:00, GH is trading at $ 161.09 in pre-market trading, down 1.04% ($1.69) from the previous close of $ 162.78. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GH after-hours price?

As of 2026-09-10 10:22:00, GH is trading at $ 163.39 in after-hours trading, up 0.37% ($0.61) from the regular-session close of $ 162.78. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GH stock trading now?

GH trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GH sit relative to its 52-week high and low?

Over the past 52 weeks, GH has traded between a low of $ 53.40 and a high of $ 176.58. At $ 161.09, the stock is positioned 87.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Guardant Health, Inc. in?

Guardant Health, Inc. (GH) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Guardant Health, Inc.'s market capitalization and where is it listed?

Guardant Health, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 21.60B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GH valued in terms of P/E ratio and EPS?

GH trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.38. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Guardant Health, Inc. pay a dividend?

Guardant Health, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.